Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study The Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group

被引:244
|
作者
Worm, S. W. [1 ]
Friis-Moller, N. [1 ]
Sabin, C. A. [1 ]
Sjol, A. [1 ]
Lundgren, J. D. [1 ]
Salbol-Brandt, R. [1 ]
Rickenbach, M. [1 ]
Pezzotti, P. [1 ]
Krum, E. [1 ]
Gras, L. [1 ]
Balestre, E. [1 ]
Sundstroem, A. [1 ]
Delforge, M. [1 ]
Fontas, E. [1 ]
Torres, F. [1 ]
Petoumenos, K. [1 ]
Kjaer, J. [1 ]
Collins, S. [1 ]
Storpher, S. [1 ]
Pearce, G. [1 ]
Rode, R. [1 ]
Weller, I. [1 ]
机构
[1] UCL, Res Dept Infect & Populat Hlth, London NW3 2PF, England
基金
美国国家卫生研究院; 瑞士国家科学基金会;
关键词
death; modifiable risk factors; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; COMBINATION ANTIRETROVIRAL THERAPY; GENERAL-POPULATION; MORTALITY; OUTCOMES; COHORT; AIDS; INTERRUPTION; INFECTION;
D O I
10.1097/QAD.0b013e32833a0918
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To investigate any emerging trends in causes of death amongst HIV-positive individuals in the current cART era, and to investigate the factors associated with each specific cause of death. Design: An observational multicentre cohort study. Methods: All HIV-positive individuals included in one of the cohorts in the Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study were included. The association between HIV-specific and non HIV-specific risk factors and death were studied using multivariable Poisson regression. Results: We observed 2482 deaths in 180 176 person-years (PY) on 33 308 individuals [rate/1000 PY = 13.8 (95% CI 13.2-14.3)]. Primary causes of death were: AIDS (n = 743; rate/1000 PY = 4.12), liver-related (341; 1.89), CVD-related (289; 1.60), non-AIDS malignancy (286; 1.59). The overall rate of death fell from 16.9 in 1999/2000 to 9.6/1000 PY in 2007/2008. Smoking was associated with CVD and non-AIDS cancers, HBV and HCV co-infection with liver-related deaths, and hypertension with liver-related and CVD deaths. Diabetes was a risk factor for all specific causes of death except non-AIDS cancers, and higher current HIV RNA for AIDS-related deaths. Lower CD4 cell counts were associated with a higher risk of death from all specific causes of death. Conclusion: Multiple potentially modifiable traditional and HIV-specific risk factors for death of HIV-infected persons were identified. The maximum reduction in mortality in HIV-infected populations will require that each of these factors be appropriately addressed. No trends in terms of emerging causes of unexpected deaths were observed, although monitoring will continue. (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:1537 / 1548
页数:12
相关论文
共 47 条
  • [1] Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
    Hatleberg, C. I.
    Ryom, L.
    Monforte, A. d'Arminio
    Fontas, E.
    Reiss, P.
    Kirk, O.
    El-Sadr, W.
    Phillips, A.
    de Wit, S.
    Dabis, F.
    Weber, R.
    Law, M.
    Lundgren, J. D.
    Sabin, C.
    [J]. HIV MEDICINE, 2018, 19 (09) : 605 - 618
  • [2] Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
    Petoumenos, Kathy
    Worm, Signe W.
    Fontas, Eric
    Weber, Rainer
    De Wit, Stephane
    Bruyand, Mathias
    Reiss, Peter
    El-Sadr, Wafaa
    Monforte, Antonella D'Arminio
    Friis-Moller, Nina
    Lundgren, Jens D.
    Law, Matthew G.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15
  • [3] Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study (vol 24, pg 1537, 2010)
    Smith, Colette J.
    Sabin, Caroline A.
    Lundgren, Jens D.
    Thiebaut, Rodolphe
    Weber, Rainer
    Law, Matthew
    Monforte, Antonella d'Arminio
    Kirk, Ole
    Friis-Moller, Nina
    Phillips, Andrew
    Reiss, Peter
    El Sadr, Wafaa
    Pradier, Christian
    Worm, Signe W.
    [J]. AIDS, 2011, 25 (06) : 883 - 883
  • [4] An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons; the Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) Study
    Friis-Moller, N.
    Ryom, L.
    Smith, C.
    Weber, R.
    Reiss, P.
    Dabis, F.
    De Wit, S.
    Monforte, A. d'Arminio
    Kirk, O.
    Fontas, E.
    Sabin, C.
    Phillips, A.
    Lundgren, J. D.
    Law, M.
    [J]. ANTIVIRAL THERAPY, 2013, 18 : A23 - A24
  • [5] An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study
    Friis-Moller, Nina
    Ryom, Lene
    Smith, Colette
    Weber, Rainer
    Reiss, Peter
    Dabis, F.
    De Wit, Stephane
    Monforte, Antonella D'Arminio
    Kirk, Ole
    Fontas, Eric
    Sabin, Caroline
    Phillips, Andrew
    Lundgren, Jens
    Law, Matthew
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (02) : 214 - 223
  • [6] Incidence and risk factors for new-onset diabetes, in HIV-infected patients -: The data collection on adverse events of Anti-HIV drugs (D:A:D) study
    De Wit, Stephane
    Sabin, Caroline A.
    Weber, Rainer
    Worm, Signe Westring
    Reiss, Peter
    Cazanave, Charles
    El-Sadr, Wafaa
    Monforte, Antonella D'Arminio
    Fontas, Eric
    Law, Matthew G.
    Friis-Moller, Nina
    Phillips, Andrew
    [J]. DIABETES CARE, 2008, 31 (06) : 1224 - 1229
  • [7] Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study
    Worm, Signe W.
    Sabin, Caroline A.
    Reiss, Peter
    El-Sadr, Wafaa
    Monforte, Antonella D'Arminio
    Pradier, Christian
    Thiebaut, Rodolphe
    Law, Matthew
    Rickenbach, Martin
    De Wit, Stephane
    Lundgren, Jens D.
    Friis-Moller, Nina
    [J]. DIABETES CARE, 2009, 32 (03) : 474 - 480
  • [8] Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
    Worm, Signe Westring
    Sabin, Caroline
    Weber, Rainer
    Reiss, Peter
    El-Sadr, Wafaa
    Dabis, Francois
    De Wit, Stephane
    Law, Matthew
    Monforte, Antonella D'Arminio
    Friis-Moller, Nina
    Kirk, Ole
    Fontas, Eric
    Weller, Ian
    Phillips, Andrew
    Lundgren, Jens
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (03): : 318 - 330
  • [9] Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores
    Dietrich, Lena G.
    Thorball, Christian W.
    Ryom, Lene
    Burkhalter, Felix
    Hasse, Barbara
    Thurnheer, Maria Christine
    Weisser, Maja
    Schmid, Patrick
    Bernasconi, Enos
    Darling, Kathrine E. A.
    Buvelot, Helene
    Fellay, Jacques
    Ledergerber, Bruno
    Tarr, Philip E.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (12): : 2145 - 2153
  • [10] Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA
    Mills, A. M.
    Schulman, K. L.
    Fusco, J. S.
    Brunet, L.
    Hsu, R.
    Beyer, A.
    Prajapati, G.
    Mounzer, K.
    Fusco, G. P.
    [J]. HIV MEDICINE, 2020, 21 (05) : 299 - 308